Abatacept for the Treatment of Giant Cell Arteritis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Giant Cell Arteritis
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 50 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04474847
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Peter A Merkel, MD, MPH University of Pennsylvania Principal Investigator: Carol A Langford, MD, MHS The Cleveland Clinic Principal Investigator: Jeffrey P Krischer, PhD University of South Florida